Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

EMA to widen public access to documents

December 1, 2010 Research and Development, Sales and Marketing EMA, European Medicines Agency, European Ombudsman, patient information, transparency

The European Medicines Agency has agreed to give greater access to documents on medicines for human and veterinary use, after …
News

New chief executive for Merck & Co

December 1, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Kenneth Frazier, Merck, Merck & Co, Richard Clark, Schering-Plough

Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
News

Change is needed, concedes NICE chief, but defends record

November 30, 2010 Sales and Marketing Andrew Dillon, NHS reform, NICE, cost-effectiveness, health technology assessment, hta, value-based pricing

The chief executive of NICE acknowledges changes are needed in how drugs are assessed in the UK – including more …
Feature

UK pharma welcomes government reforms

November 30, 2010 Manufacturing and Production, Research and Development, Sales and Marketing ABHI, ABPI, BIA, R&D tax credits, UK pharma, patent box

The UK pharma industry has responded warmly to government plans to review how best to create optimum conditions for private …
News
idea_pharma_graham_cox

Graham Cox joins Idea Pharma

November 29, 2010 Sales and Marketing Graham Cox, IDEA Pharma, appointment, sales and marketing

Idea Pharma has appointed Graham Cox as a senior consultant. He joins from AstraZeneca, where he was originally a client …
Appointment

Pharma unprepared for personalised oncology

November 29, 2010 Research and Development, Sales and Marketing Cancer, ESMO, ESMO Cancer Biology for Clinicians Symposium, oncology, personalised medicine

The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …
News
Pfizer headquarters

Pfizer submits Gaucher drug to EMA

November 29, 2010 Sales and Marketing Cerezyme, EMA, Gaucher disease, Genzyme, Pfizer, Protalix BioTherapeutics, Shire, Vpriv, taliglucerase alfa

Pfizer and partner Protalix BioTherapeutics have submitted a marketing application to European regulator the EMA for their Gaucher disease candidate …
News
Doctors.net.uk

Doctor’s networks – an emerging engagement channel

November 29, 2010 Medical Communications, Sales and Marketing Len Starnes, PatientsLikeMe, doctors' social networks, social media, social networking

The last four years have seen an extraordinary growth in physicians’ social networks and a rapid increase in levels of …
Feature
Novartis’ Afinitor (everolimus)

Novartis fails to sway NICE with Afinitor deal

November 26, 2010 Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis, advanced renal cell carcinoma, everolimus

Novartis has failed to convince NICE that its revised patient access scheme for Afinitor would make the kidney cancer drug …
News

NHS Atlas shows health outcomes variation across England’s PCTs

November 26, 2010 Sales and Marketing NHS, NHS Atlas, NHS reform, PCTs, Primary Care Trusts, healthcare variation, statin prescribing

A new tool will allow observers to compare at a glance what 152 Primary Care Trusts (PCTs) in England spend …
News
abpi_sam_ogden

Roche’s Sam Ogden joins the ABPI

November 25, 2010 Medical Communications, Sales and Marketing ABPI, Sam Ogden, appointment, medical communications, sales and marketing

The ABPI has appointed Sam Ogden as membership engagement account director. She is currently head of in-field effectiveness at Roche …
Appointment
European Parliament

Europe tightens patient information proposals

November 25, 2010 Medical Communications, Sales and Marketing European Commission, European Parliament, dtc, patient information

European restrictions on patient access to medicines information are still on track to be relaxed, but the proposed changes have …
News

Gilead’s pill shows promise in HIV prevention

November 25, 2010 Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir

Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …
News

UN says Treatment 2.0 approach needed for AIDS

November 25, 2010 Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS

A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …
News
Tarceva tablet

Roche set to challenge NICE Tarceva decision

November 25, 2010 Sales and Marketing NICE, Roche, Roche UK, Tarceva, erlotinib, lung cancer

NICE has again rejected Roche’s lung cancer drug Tarceva in its second round of draft guidance. Tarceva (erlotinib) was being …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026